New Delhi: The Brazilian health regulator on Monday scrapped the approval application of Bharat Biotech’s Covaxin setting the stage for the termination of a multi-million dollar deal Bharat Biotech had with Brazil to seek Covaxin doses to the South American nation. The US $324 million deal was signed in February. TNS
Advertisement
Advertisement
×
Unlock Exclusive Insights with The Tribune Premium
Take your experience further with Premium access.
Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Combo
Yearly
Monthly
Already a Member? Sign In Now
Advertisement
Advertisement
Advertisement



